# Hansson Lennart

> Hansson Lennart is a funding round investor at Industrifonden backing Medical and Biopharma. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Industrifonden](https://shizune.co/investors/profile/industrifonden)
- Total investments: 2
- Last investment: Feb 2014
- Lead investor: 0%
- Last updated: Aug 2026

Hansson Lennart is a funding round investor at Industrifonden focused on Medical and Biopharma. Lennart has post-doctoral and research in molecular genetics at the University of Umeå worked in the pharmaceutical industry for about 20 years in various management positions in both large and small companies; KabiGen, AstraZeneca, Symbicom, Arexis and Biovitrum. As CEO of Arexis 2001-05 deepened the network of contacts and experience frominternational venture capital industry since 2006 Lennart has worked with investment in the life sciences industry in areas such Karolinska Development and from 2008 at the Industrial Development Fund as Head of Life Science business area.Lennart has worked in about 30 different boards and sits today in eg Pharma Link, Index Pharmaceuticals, Medtentia, Uminova Invest, Lund Bioscience and CMC Contrast. In addition, he participates in the Vancouver-based investment company Beacon PE.Spare time is devoted to nature, art and gardening.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 1 | 50% |
| Private Equity | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| InDex Pharmaceuticals | InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer. | $20M |  | Feb 25, 2014 |  |
| InDex Pharmaceuticals | InDex Pharmaceuticals AB is a clinical stage biopharmaceutical company building a leading immunotherapy franchise based on its TLR platform (toll-like receptors). It discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer. | $7.2M | Private Equity | Jan 21, 2011 |  |

2 of 2 investments shown.

## Co-investors
- [SEB Venture Capital](https://shizune.co/investors/profile/seb-venture-capital) — VC Fund, 2 deals together
- [Neomed Management](https://shizune.co/investors/profile/neomed-management) — VC Fund, 1 deal together

## About Industrifonden

VC Fund · Stockholm, Sweden

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

5 contacts available at Industrifonden.

| Name | Title | Profile |
| --- | --- | --- |
| Anna Ljungdahl | Investment Manager | https://shizune.co/investors/profile/anna-ljungdahl |
| Bita Sehat | Investment Manager of Life Science | https://shizune.co/investors/profile/bita-sehat |
| Hadar Cars | Senior Investment Director | https://shizune.co/investors/profile/hadar-cars |
| Hansson Lennart | Business Unit Manager Life Science | https://shizune.co/investors/profile/hansson-lennart |
| Jonas Brambeck | Investment Manager - Life Science | https://shizune.co/investors/profile/jonas-brambeck |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Hansson Lennart invest in?

Hansson Lennart invests primarily in Medical, Biopharma and Biotechnology startups, most often at Funding Round and Private Equity stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hansson Lennart last invest?

The most recent investment recorded for Hansson Lennart closed in Feb 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co